Danielle Lavery

Danielle Lavery, PhD PMP, is the Senior Director of Regulatory CMC at ImmunityBio, Inc. They have extensive experience in drug development, having served as Associate Director and Director at NovaRock Biotherapeutics Ltd. Previously, they were an Upstream Scientist II at Adello Biologics, where they led the development of a biosimilar monoclonal antibody. With a strong background in research from Queen Mary University of London and Barts Cancer Institute, Danielle specializes in regulatory filing strategies for the U.S. and China while fostering collaborative partnerships in the industry. They are currently pursuing a Master’s and Bachelor’s degree in Genetics and Biology from the University of Connecticut.